This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Emmanuelle Porte
As a Corporate partner in the Bird & Bird Life Sciences team in Paris, I mainly advise innovative companies financed by venture capital, in particular biotech/medtech, digital health, and wellness companies.
3
Articles
0
Comments
Managing Scientific Collaboration Agreements within the French Healthtech Sector
Scientific Collaboration Agreements allow a public servant, most of the time a researcher, (who...
November 9, 2020
5 min read
French Healthtech in the Covid crisis: when strategic issues lead to growth
The strategic challenges of the French Healthtech sector - health, innovation, sovereignty - are undeniably...
October 13, 2020
6 min read
The allocation of BSPCEs (Bons de Souscription de Parts de Créateurs d’Entreprise) to independent board directors: a small revolution for joint stock companies, a real breakthrough for the biotech world
Biotech and medtech companies operate in an international environment where the composition of their...
October 30, 2019
2 min read